Wns Hldgs Stock Price, News & Analysis

WNS company HealthHelp has partnered with Covera Health to enhance its Diagnostic Imaging program. This strategic partnership aims to integrate Covera's Centers of Excellence (CoE) program with HealthHelp's services, improving access to high-quality radiological care for health plan members. The collaboration is designed to reduce misdiagnoses and unnecessary medical expenses while leveraging advanced analytics for better patient outcomes. This initiative reflects HealthHelp's commitment to evidence-based medicine and enhancing care quality through innovative solutions.

WNS (Holdings) Limited (NYSE: WNS) reported fiscal Q2 2022 results with revenue reaching $273.6 million, a 22.9% increase year-over-year. Profit rose to $32.1 million, reflecting strong demand and effective cost management. Adjusted diluted earnings per ADS were $0.86, up 17.8%. The firm added 8 new clients and expanded 32 existing relationships. WNS updated its fiscal 2022 guidance, forecasting revenue less repair payments between $984 million and $1,016 million. The company anticipates continued growth despite ongoing COVID-19 challenges.

WNS (Holdings) Limited (NYSE: WNS) will announce its fiscal 2022 second quarter financial results on October 28, 2021, at 6:00 a.m. Eastern. A teleconference will follow at 8:00 a.m. Eastern, featuring CEO Keshav Murugesh, CFO Sanjay Puria, and COO Gautam Barai. The results will include performance metrics for the quarter ended September 30, 2021. Interested parties can join via the company’s investor relations website. A replay will be available for one week post-call.

WNS (Holdings) Limited (NYSE: WNS) has entered a partnership with Pacific Life to enhance operations for its Pension Risk-Transfer (PRT) business. The collaboration aims to transform onboarding and service processes through advanced digital analytics and customer experience strategies. This innovative approach will optimize operational efficiency and improve customer experiences, boosting Pacific Life's scalability and speed-to-market. With over 12,000 professionals dedicated to the insurance sector, WNS leverages AI and machine learning to drive significant advancements in service delivery.

WNS (Holdings) Limited has announced that Adrian T. Dillon will retire from the Board of Directors and his position as Chairman effective September 20, 2021. Timothy L. Main will take over as Chairman starting September 21, 2021. Dillon has served on the board for 9 years and is credited with significantly contributing to WNS's success in the BPM industry. CEO Keshav R. Murugesh expressed gratitude for Dillon's leadership and looks forward to working with Main to propel the company further.

WNS (Holdings) Limited (NYSE: WNS) announced its annual general meeting for shareholders on September 23, 2021, at 11:00 am London Time, to be held at Malta House, London. Shareholders can participate virtually or via phone. The company urged shareholders to appoint the Chairman as their proxy for voting. Additionally, the annual report for the fiscal year ending March 31, 2021, was filed with the SEC on May 14, 2021, and relevant documents are accessible on the company's website. WNS is a leading BPM provider with over 46,918 professionals globally.

WNS (Holdings) Limited (NYSE: WNS) has launched PRECIZON, a cloud-based Competitive Intelligence platform tailored for the Pharma, Bio-pharma, and Life Sciences sectors. The platform offers real-time insights by integrating commercial and public data, enhanced with advanced analytics and visualizations. It aims to provide companies a comprehensive view of the market landscape and competitor drug approval timelines. WNS emphasizes that PRECIZON enables informed decision-making, helping businesses adapt to dynamic market conditions while optimizing R&D spending.